| TRADING CENTER |
| US lawsuit over Merck bone drug Fosamax dismissed - Reuters | |
| The Side Effect of Developing Obesity Drugs - MotleyFool.com | |
| Positive Opinion for Merck Drug - Analyst Blog - Zacks.com | |
| MARKET SNAPSHOT: U.S. Stocks Rally Toward Fresh 13-month Highs - Dow Jones | |
| Judge Dismisses Second Bellwether Case Involving Fosamax - Dow Jones | |
| Remember, Remember the Strength of November ($) - at TheStreet.com | |
| Get Ready for the Fall? - MotleyFool.com | |
| MARKET SNAPSHOT: Energy, Materials Pace U.S. Gains; Dollar Declines - Dow Jones | |
| Encouraging Data on J&J Drug - Analyst Blog - Zacks.com | |
| Good News for Bristol-Myers - Analyst Blog - Zacks.com | |
| Are These Dividends Too Good to Be True? - MotleyFool.com | |
| Cramer on BloggingStocks: Sanofi has lots of upside catalysts - Bloggingstocks.com | |
| Sanofi Has Lots of Upside Catalysts ($) - at TheStreet.com | |
| Sanofi chief lays out distinctive strategy - FT.com | |
| WRAPUP 2-Healthcare reform faces challenges in U.S. Senate - Reuters |
| 2008 Revenue: | $23.9 B | Headquarters: Whitehouse Station, NJ |
| Employees: | 55,200 | CEO: Richard T. Clark |
| Net Income: | $7.8 B | Industry: |
| Market Cap: | $76.9 B | Website: www.merck.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| MRK | 36.42 | -0.04 / -0.11% | 36.46 | 36.96 | 36.19 | Profile Chart News |